Eli Lilly has secured Chinese regulatory approval for its oral GLP-1 weight-loss drug, orforglipron, becoming the first ...

Nvidia CEO prediction markets put Ian Buck at 35% and Colette Kress at 30%; a report says the board is preparing to remove ...

Chevron and ExxonMobil both banked a war windfall and have already started giving it back to the shareholders. See why CVX ...

For third quarter end, September 30, 2026, For Income (Class A shares, net asset value) had a total return of -1.02%. Read ...

AMETEK is rated Hold due to strong organic growth and robust orders but elevated valuation and increased debt from ...

One of the best growth stories in recent years has come from Palantir . The technology company has seen revenue growth ...

Review the Q3 2026 commentary for Voya Small Cap Growth Strategy detailing top performance detractors and contributors. Read ...

Markets are anxious about near-term inflation surprises but seem to view structural inflation benignly. Long-term market ...

Global fixed-income markets faced volatility from geopolitical risks and inflation. Read the full Q3 performance update for ...

Strategy Q3 2026 update highlights key detractors, contributors, and market outlook. Read the full commentary to learn more.

The U.S. CRE Health Index currently scores U.S. commercial real estate at 46 out of 100, placing the market on the slightly ...

A.O. Smith remains a Hold as the China divestiture unlocks $350M potential returns but does not resolve valuation concerns.